Serial MR imaging and 1H-MR spectroscopy in monozygotic twins with Tay-Sachs disease

Neuropediatrics

Volumn 39, Issue 5, 2008, Pages 259-263

  Imamura, A ^a,b   Miyajima, H ^a   Ito, R ^a   Orii, K O ^a  

^a GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

Lactate; MR imaging; MR spectroscopy; Myoinositol; N acetylaspartate; Tay Sachs disease

Indexed keywords

CREATININE; N ACETYLASPARTIC ACID; VALPROIC ACID;

ARTICLE; BASAL GANGLION; BRAIN METABOLISM; CASE REPORT; CHILD; CLINICAL FEATURE; CORPUS STRIATUM; DIAGNOSTIC VALUE; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; INTRACTABLE EPILEPSY; LABORATORY TEST; MONOZYGOTIC TWINS; MYOCLONUS SEIZURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TAY SACHS DISEASE; THALAMUS; WHITE MATTER;

ASPARTIC ACID; BASAL GANGLIA; BRAIN; CEREBRAL CORTEX; CHILD, PRESCHOOL; CHOLINE; CORPUS CALLOSUM; CREATINE; DISEASE PROGRESSION; DISEASES IN TWINS; DNA MUTATIONAL ANALYSIS; DOMINANCE, CEREBRAL; ENERGY METABOLISM; EPILEPSIES, MYOCLONIC; FEMALE; GANGLIOSIDOSES, GM2; HEXOSAMINIDASE A; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NERVE FIBERS, MYELINATED; NEUROLOGIC EXAMINATION; THALAMUS; TWINS, MONOZYGOTIC;

EID: 63249122392     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1202285     Document Type: Article

References (16)

1. Alkan A, Kutlu R, Yakinci C et al. Infantile Sandhoffs disease: Multivoxel magnetic resonance spectroscopy findings. J Child Neurol 2003; 18: 425-428
2. Aydein K, Bakir B, Tatli B et al. Proton MR spectroscopy in three children with Tay-Sachs disease. Pediatr Radiol 2005; 35: 1081-1085
3. Fukumizu M, Yoshikawa H, Takashima S et al. Tay-Sachs disease: progression of changes on neuroimaging in four cases. Neuroradiology 1992; 34: 483-486
4. Gravel RA, Kaback MM, Proia RL et al. The GM2 gangliosidoses In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease, 8th edn. McGraw-Hill, New York; 2001; 3827-3877
5. Grosso S, Farnetani MA, Berardi R et al. GM2 gangliosidosis variant B1 Neuroradiological findings. J Neurol 2003; 250: 17-21
6. 1H-Magnetic resonance spectroscopy in a case of Moyamoya disease with revascularization surgery. Pediatr Int 2006; 48: 426-429
7. 1H-MR spectroscopy in a case of cerebral infarction with transient cerebral arteriopathy. Brain Dev 2004; 26: 535-538
8. 1H-MR spectroscopy of unidentified bright objects in a case of neurofibromatosis type 1. Brain Dev 2005; 27: 595-597
9. 1H-MR spectroscopy in a case of juvenile Alexander disease. Brain Dev 2002; 24: 723-726
10. Inglese M, Nusbaum AO, Pastores GM et al. MR imaging and proton spectroscopy of neuronal injury in late-onset GM2 gangliosidosis. AJNR Am J Neuroradiol 2005; 26: 2037-2042
11. 1H-MR spectroscopy and clinical manifestation with tuberous sclerosis complex. Neuropediatrics 2007; 38: 126-129
12. Mizuno S, Takahashi Y, Kato Z et al. Magnetic resonance spectroscopy of tubers in patients with tuberous sclerosis. Acta Neurol Scand 2000; 102: 175-178
13. Mugikura S, Takahashi S, Kurihara N et al. MR findings in Tay-Sachs disease. J Comut Assist Tomogr 1996; 20: 551-555
14. Schulte FJ. Clinical course of GM2 Gangliosidoses A correlative attempt. Neuropediatrics 1984; 15: 66-70
15. Tanaka A, Fujimoto M, Choeh K et al. Novel mutations, including the second most common in Japan, in the beta-hexosaminidase alpha subunit gene, and a simple screening of Japanese patients with TaySachs disease. J Hum Genet 1999; 44: 91-95
16. Yoshikawa H, Yamada K, Sakuragawa N. MRI in the early stage of TaySachs disease. Neuroradiology 1992; 34: 394-395